While the dust continues to settle on Canada’s new legislation that came into effect with the Patent Act of 2019, changes made to the Patented Medicine Regulations regarding excessive pricing of patented medicines have also generated a substantial amount of work, with some significant court decisions. However, it is not...
Read more
While the dust continues to settle on Canada’s new legislation that came into effect with the Patent Act of 2019, changes made to the Patented Medicine Regulations regarding excessive pricing of patented medicines have also generated a substantial amount of work, with some significant court decisions. However, it is not just the pharmaceutical industry that has kept the nation’s practitioners busy; other significant disputes have also occurred in the oil and gas and technology industries. Over at the Canadian Intellectual Property Office (CIPO), October 2022 saw the implementation of claim fees and continued examination fees. Previously there were no fees linked with the number of claims made in Canada, nor were there fees associated with the number of examinations. These new guidelines follow the introduction of the Canada-United States-Mexico Agreement (CUSMA) and CIPO’s goal to minimise pending patent applications and streamline the examination process.
Show less
